Paper2249335
7-Hydroxymethotrexate concentrations in serum and cerebrospinal fluid of children with acute lymphoblastic leukemia.
Borsi JD and 4 others. Cancer Chemother Pharmacol, 1990. Cited by 11 papers, by iCite.
Cite this record
ConductScience Library. 7-Hydroxymethotrexate concentrations in serum and cerebrospinal fluid of children with acute lymphoblastic leukemia. Papers, record 2249335. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2249335
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- 7-Hydroxymethotrexate concentrations in serum and cerebrospinal fluid of children with acute lymphoblastic leukemia.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Folic Acid Antagonists | Major topic |
| Methotrexate | Major topic |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | Major topic |
| Aging | |
| Antineoplastic Agents | |
| Child | |
| Child, Preschool | |
| Humans | |
| Infant | |
| Infusions, Intravenous | |
| Prognosis |
Source PubMed
References17
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 3467178 | [New aspects of the determination of blood methotrexate levels in leukemic children]. | Monatsschr Kinderheilkd | 1986 | https://conductscience.org/library/papers/3467178 | PubMed |
| 2 | 6600662 | Methotrexate cerebrospinal fluid and serum concentrations after intermediate-dose methotrexate infusion. | Clin Pharmacol Ther | 1983 | https://conductscience.org/library/papers/6600662 | PubMed |
| 3 | 1062383 | 7-Hydroxymethotrexate as a urinary metabolite in human subjects and rhesus monkeys receiving high dose methotrexate. | J Clin Invest | 1976 | https://conductscience.org/library/papers/1062383 | PubMed |
| 4 | 2414788 | The cellular pharmacology of methotrexate. | Pharmacol Ther | 1985 | https://conductscience.org/library/papers/2414788 | PubMed |
| 5 | 6715337 | Synthesis and properties of 7-hydroxymethotrexate polyglutamyl derivatives in Ehrlich ascites tumor cells in vitro. | J Biol Chem | 1984 | https://conductscience.org/library/papers/6715337 | PubMed |
| 6 | 6692419 | Interactions between 7-hydroxymethotrexate and methotrexate at the cellular level in the Ehrlich ascites tumor in vitro. | Cancer Res | 1984 | https://conductscience.org/library/papers/6692419 | PubMed |
| 7 | 7251770 | Rapid and simple method for the measurement of methotrexate and 7-hydroxymethotrexate in serum by high-performance liquid chromatography. | J Chromatogr | 1981 | https://conductscience.org/library/papers/7251770 | PubMed |
| 8 | 3456079 | Clinical pharmacodynamics of high-dose methotrexate in acute lymphocytic leukemia. Identification of a relation between concentration and effect. | N Engl J Med | 1986 | https://conductscience.org/library/papers/3456079 | PubMed |
| 9 | 6141424 | Methotrexate systemic clearance influences probability of relapse in children with standard-risk acute lymphocytic leukaemia. | Lancet | 1984 | https://conductscience.org/library/papers/6141424 | PubMed |
| 10 | 7189691 | The role of 7-hydroxymethotrexate during methotrexate anti-cancer therapy. | Cancer Lett | 1980 | https://conductscience.org/library/papers/7189691 | PubMed |
| 11 | 6883624 | Plasma levels of 7-hydroxymethotrexate after high-dose methotrexate treatment. | Cancer Chemother Pharmacol | 1983 | https://conductscience.org/library/papers/6883624 | PubMed |
| 12 | 3472638 | A comparative study on the pharmacokinetics of methotrexate in a dose range of 0.5 g to 33.6 g/m2 in children with acute lymphoblastic leukemia. | Cancer | 1987 | https://conductscience.org/library/papers/3472638 | PubMed |
| 13 | 3479231 | Systemic clearance of methotrexate in the prognosis of acute lymphoblastic leukemia in children. | Cancer | 1987 | https://conductscience.org/library/papers/3479231 | PubMed |
| 14 | 720376 | Pharmacokinetics of high-dose methotrexate treatment in children. | Eur J Clin Pharmacol | 1978 | https://conductscience.org/library/papers/720376 | PubMed |
| 15 | 3472677 | Prognostic importance of systemic clearance of methotrexate in childhood acute lymphoblastic leukemia. | Cancer Chemother Pharmacol | 1987 | https://conductscience.org/library/papers/3472677 | PubMed |
| 16 | 6956440 | Pharmacokinetics of methotrexate and 7-hydroxymethotrexate following infusions of high-dose methotrexate. | Cancer Treat Rep | 1982 | https://conductscience.org/library/papers/6956440 | PubMed |
| 17 | 6971042 | Intermediate dose methotrexate (IDM) in childhood acute lymphocytic leukemia in Norway. Preliminary results of a national treatment program. | Acta Paediatr Scand | 1981 | https://conductscience.org/library/papers/6971042 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2249335
GET https://conductscience.org/api/papers/v1/2249335/authors